Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2020 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
ORIC on Nasdaq
Shares outstanding
97,866,034
Price per share
$12.05
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
119,658,180
Total reported value
$979,615,217
% of total 13F portfolios
0%
Share change
+12,274,879
Value change
+$96,291,766
Number of holders
164
Price from insider filings
$12.05
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VIKING GLOBAL INVESTORS LP 10% +8.8% $95,149,860 +$23,507,430 8,729,345 +33% VIKING GLOBAL INVESTORS LP 30 Jun 2025
Nextech Crossover I GP S.a r.l. 8.4% $78,072,743 7,162,637 Nextech Crossover I GP S.a. r.l. 30 Jun 2025
EcoR1 Capital, LLC 6.9% $73,336,464 6,728,116 EcoR1 Capital, LLC 29 Jul 2025
Venrock Healthcare Capital Partners III, L.P. 5.8% -24% $57,556,972 -$9,335,442 5,676,230 -14% Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
BlackRock, Inc. 5.6% +35% $44,773,610 +$15,158,006 5,473,145 +51% BlackRock, Inc. 31 Dec 2025
SR ONE CAPITAL MANAGEMENT, LLC 4.8% -13% $50,307,686 4,615,384 0% SR One Capital Management, LLC 12 Aug 2025
ALKEON CAPITAL MANAGEMENT LLC 4.6% $54,049,152 4,504,096 Alkeon Capital Management LLC 30 Sep 2025
Point72 Asset Management, L.P. 5.1% $23,372,809 4,401,659 Point72 Asset Management, L.P. 29 May 2025
COLUMN GROUP II, LP 3.7% $48,612,534 3,644,118 Peter Svennilson 30 Sep 2025
FMR LLC 3.5% $13,967,797 2,467,809 FMR LLC 31 Dec 2024
Frazier Life Sciences Public Fund, L.P. 2% $7,981,692 1,410,193 James N. Topper 31 Mar 2025

As of 31 Dec 2025, 164 institutional investors reported holding 119,658,180 shares of Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC). This represents 122% of the company’s total 97,866,034 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) together control 94% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Nextech Invest, Ltd. 7.3% 7,162,637 0% 5.7% $58,590,371
EcoR1 Capital, LLC 6.9% 6,728,116 0% 2.5% $55,035,989
VIKING GLOBAL INVESTORS LP 6.7% 6,572,691 -0% 0.14% $53,764,612
BlackRock, Inc. 6% 5,875,053 +11% 0% $48,057,934
VR ADVISER, LLC 5.8% 5,676,230 -14% 2.3% $46,431,561
Pfizer Inc 5.5% 5,376,344 0% 19% $43,978,494
VANGUARD GROUP INC 4.6% 4,541,974 -2.3% 0% $37,153,347
SR One Capital Management, LP 4.6% 4,514,929 0% 5.3% $37,753,841
ALKEON CAPITAL MANAGEMENT LLC 4.6% 4,504,096 0% 0.16% $36,843,505
STATE STREET CORP 4.4% 4,258,397 +77% 0% $34,833,687
NEA Management Company, LLC 4.2% 4,118,621 0% 1.7% $33,690,320
ORBIMED ADVISORS LLC 3.7% 3,641,756 0% 0.64% $29,789,564
Column Group LLC 3.6% 3,540,777 0% 35% $28,963,556
PRICE T ROWE ASSOCIATES INC /MD/ 3.4% 3,295,122 +15% 0% $26,955,000
Point72 Asset Management, L.P. 3% 2,923,077 +12% 0.04% $23,910,770
FMR LLC 2.5% 2,478,922 -1.9% 0% $20,277,582
CITADEL ADVISORS LLC 2.5% 2,434,710 +103% 0.01% $19,915,928
Paradigm Biocapital Advisors LP 2.5% 2,401,217 0.53% $19,641,955
Vivo Capital, LLC 2.2% 2,118,384 -32% 1.1% $17,328,381
First Turn Management, LLC 2.1% 2,010,307 -6.9% 1.9% $16,444,311
GOLDMAN SACHS GROUP INC 2% 1,939,285 +114% 0% $15,863,351
MPM BIOIMPACT LLC 1.8% 1,798,717 +4% 1.7% $14,713,505
GEODE CAPITAL MANAGEMENT, LLC 1.8% 1,750,694 +7.4% 0% $14,323,065
ROYCE & ASSOCIATES LP 1.5% 1,507,301 +3.3% 0.13% $12,329,722
DIMENSIONAL FUND ADVISORS LP 1.3% 1,227,230 +55% 0% $10,037,866

Institutional Holders of Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 119,658,180 $979,615,217 +$96,291,766 $8.18 164
2025 Q3 106,492,104 $1,277,897,818 +$159,574,138 $12.00 151
2025 Q2 93,349,298 $947,499,065 +$169,716,912 $10.15 140
2025 Q1 79,209,337 $442,004,992 +$11,923,513 $5.58 142
2024 Q4 75,794,185 $611,682,254 -$16,308,147 $8.07 129
2024 Q3 69,823,199 $715,076,569 +$22,655,622 $10.25 121
2024 Q2 67,575,796 $477,762,911 +$20,174,043 $7.07 111
2024 Q1 63,945,767 $879,254,046 +$197,777,720 $13.75 110
2023 Q4 50,638,764 $465,880,631 +$34,655,080 $9.20 91
2023 Q3 48,053,106 $290,723,321 +$14,148,790 $6.05 89
2023 Q2 45,537,877 $353,374,535 +$99,111,683 $7.76 83
2023 Q1 33,075,099 $188,527,951 +$3,515,469 $5.70 70
2022 Q4 32,430,291 $192,141,081 +$135,543 $5.89 64
2022 Q3 32,701,288 $104,643,704 -$1,866,676 $3.20 69
2022 Q2 32,837,327 $147,127,000 -$6,223,365 $4.48 77
2022 Q1 33,856,070 $180,750,917 -$7,186,800 $5.34 94
2021 Q4 34,857,324 $512,119,938 -$36,775,082 $14.70 79
2021 Q3 31,534,174 $659,370,855 +$8,490,366 $20.91 78
2021 Q2 36,145,561 $639,409,737 +$2,954,162 $17.69 78
2021 Q1 35,685,685 $874,284,848 +$71,774,159 $24.50 82
2020 Q4 32,607,853 $1,103,814,951 +$273,075,064 $33.85 76
2020 Q3 22,151,969 $552,859,000 +$7,647,968 $25.01 53
2020 Q2 21,388,813 $718,339,063 +$718,339,063 $33.73 64